SEC Form 4 · accession 0001022079-17-000104
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine T. Doherty
Officer — SVP, Group Exec. Clin. Fran.
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2017 | A | 12,520 | $98.12 | A | 87,809 | D | |
| Common StockF2 | Mar 2, 2017 | F | 6,492 | $98.12 | D | 81,317 | D | |
| Common Stock | Mar 2, 2017 | S | 1,134 | $98.25 | D | 80,183 | D | |
| Common Stock | Mar 3, 2017 | S | 6,028 | $98.29 | D | 74,155 | D | |
| Common StockF4 | holding | — | — | — | 3,767 | I | 401(k)/SDCP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d).
- F2Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
- F3The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 30, 2017.
- F4These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.